Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. Atomoxetine is a selective norepinephrine re-uptake inhibitor. It appears to work by blocking or slowing the reabsorption of norepinephrine...
Strattera (atomoxetine hcl) is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Strattera should be used as part of a total treatment program for ADHD that may include counseling or other therapies...
People with a gene defect have greater preferences for high-fat, but not high sugar foods, drawing a direct link between food choice and genetic variants.
New research finds even with charity or cash incentives, regularly wearing activity trackers may increase exercise levels, but not enough to boost health.
This article provides a brief summary of anatomy, purpose, and disorders of the cerebellum, also offering tips on preserving brain health.